We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $5.12B
1-Year Est. Return 314.02%
This Fund
S&P 500
This Quarter Est. Return
+11.72%
1 Year Est. Return
+314.02%
3 Year Est. Return
+1,498.66%
5 Year Est. Return
+2,457.67%
10 Year Est. Return
+48,821.41%
AUM
$3.39B
AUM Growth
-$174M
Cap. Flow
-$28.5M
Cap. Flow %
-0.84%
Top 10 Hldgs %
46.4%
Holding
115
New
19
Increased
20
Reduced
20
Closed
16

Top Buys

Rank Stock Value
1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$127M
2
ACLX
Arcellx
ACLX
+$37.7M
3
SNY icon
Sanofi
SNY
+$37.4M
4
IOVA icon
Iovance Biotherapeutics
IOVA
+$37M
5
APLS
Apellis Pharmaceuticals
APLS
+$32M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$109M
2
SRPT icon
Sarepta Therapeutics
SRPT
+$50.4M
3
VRNA
Verona Pharma
VRNA
+$46.4M
4
ALBO
Albireo Pharma Inc
ALBO
+$38M
5
CINC
CinCor Pharma, Inc. Common Stock
CINC
+$31.7M

Sector Composition

Rank Sector Weight
1 Healthcare 99.49%
2 Financials 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACRS icon
101
Aclaris Therapeutics
ACRS
$715M
– –
-341,239
Closed -$5.37M
MDGL icon
102
PUT
Madrigal Pharmaceuticals
MDGL
$12.6B
– –
-300,000
Closed -$87.1M
PEN icon
103
Penumbra
PEN
$12.6B
– –
-25,400
Closed -$5.65M
PRCT icon
104
Procept Biorobotics
PRCT
$1.02B
– –
-64,537
Closed -$2.68M
PRVA icon
105
Privia Health
PRVA
$3.04B
– –
-90,000
Closed -$2.04M
FLNA
106
PUT
Filana Therapeutics
FLNA
$42M
– –
-150,000
Closed -$4.43M
SCPH
107
DELISTED
scPharmaceuticals
SCPH
– –
-952,380
Closed -$6.83M
NVRO
108
DELISTED
NEVRO CORP.
NVRO
– –
-30,000
Closed -$1.19M
RVNC
109
DELISTED
Revance Therapeutics, Inc.
RVNC
– –
-729,097
Closed -$13.5M
PNT
110
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
– –
-500,000
Closed -$3.65M
DICE
111
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
– –
-293,362
Closed -$9.15M
ISO
112
DELISTED
IsoPlexis Corporation Common Stock
ISO
– –
-4,095,498
Closed -$6.35M
ALBO
113
DELISTED
Albireo Pharma Inc
ALBO
– –
-1,757,160
Closed -$38M
CINC
114
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
– –
-2,576,325
Closed -$31.7M
HZNP
115
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-960,000
Closed -$109M
1 2 3 4
5

Similar funds

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return
CIA
Choate Investment Advisors Boston, Massachusetts $5.11B AUM 17.2% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.11B AUM 8.63% 1-Year Est. Return
CIC
Carnegie Investment Counsel Pepper Pike, Ohio $5.13B AUM 22.98% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.1B AUM 8.43% 1-Year Est. Return

Perceptive Advisors's Q1 2023 Portfolio in Review

As of Q1 2023, Perceptive Advisors held 115 positions worth $3.39B, down 4.9% from $3.56B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Perceptive Advisors's Q1 2023 filing shows 19 new, 20 increased, 20 reduced and 16 closed positions. Its largest new stake was Reata Pharmaceuticals, Inc. Class A Common Stock: 2,169,276 shares worth $197M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $109M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 97% a quarter earlier, followed by Financials.

  • Perceptive Advisors's largest Q1 2023 buy was Reata Pharmaceuticals, Inc. Class A Common Stock: 2,169,276 shares worth $197M.
  • Perceptive Advisors added most to Arcellx in Q1 2023, an estimated $37.7M increase.
  • Perceptive Advisors's biggest Q1 2023 reduction was Sarepta Therapeutics, cutting an estimated $50.4M.
  • Perceptive Advisors fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, selling an estimated $109M.
  • Perceptive Advisors's ten largest holdings make up 46% of its $3.39B portfolio in Q1 2023.
  • Perceptive Advisors opened 19 new positions and closed 16 in Q1 2023.
  • Perceptive Advisors's portfolio value fell 4.9% quarter-over-quarter to $3.39B.

Based on Perceptive Advisors's 13F filing for Q1 2023, filed 15 May 2023.